1-3 of 3
Shannon K. McWeeney
Close
Sort by
Journal Articles

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia

Stephen E. Kurtz, Christopher A. Eide, Andy Kaempf, Nicola Long, Daniel Bottomly, Olga Nikolova, Brian J. Druker, Shannon K. McWeeney, Bill H. Chang, Jeffrey W. Tyner, Anupriya Agarwal
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3062–3067.
https://doi.org/10.1182/bloodadvances.2021006307
Published: 2022
Includes: Supplemental data
Journal Articles

Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway

Kaycee B. Moshofsky, Hyun J. Cho, Guanming Wu, Kyle A. Romine, Matthew T. Newman, Yoko Kosaka, Shannon K. McWeeney, Evan F. Lind
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3038–3051.
https://doi.org/10.1182/bloodadvances.2019000574
Published: 2019
Journal Articles

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Xi Luo, Simone Feurstein, Shruthi Mohan, Christopher C. Porter, Sarah A. Jackson, Sioban Keel, Michael Chicka, Anna L. Brown, Chimene Kesserwan, Anupriya Agarwal, Minjie Luo, Zejuan Li, Justyne E. Ross, Panagiotis Baliakas, Daniel Pineda-Alvarez, Courtney D. DiNardo, Alison A. Bertuch, Nikita Mehta, Tom Vulliamy, Ying Wang, Kim E. Nichols, Luca Malcovati, Michael F. Walsh, Lesley H. Rawlings, Shannon K. McWeeney, Jean Soulier, Anna Raimbault, Mark J. Routbort, Liying Zhang, Gabriella Ryan, Nancy A. Speck, Sharon E. Plon, David Wu, Lucy A. Godley
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2962–2979.
https://doi.org/10.1182/bloodadvances.2019000644
Published: 2019
Includes: Supplemental data